BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Saint Health Group//Regulatory Radar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:md-26-190-p-proposed--comment@sainthealthgroup.com
DTSTAMP:20261112T000000Z
DTSTART;VALUE=DATE:20261130
DTEND;VALUE=DATE:20261201
SUMMARY:[MD] Comment deadline: Maryland proposes pharmacist opioid use diso
 rder treatment under prescriber agreements
DESCRIPTION:If you run an outpatient SUD program or OTP in Maryland with pr
 escribers who could partner with pharmacists on buprenorphine or other OUD
  medication management\, read the proposed protocol and registration requi
 rements and comment by November 30\, 2026. Plan how a pharmacist partner w
 ould fit your medication workflow\, PDMP checks and DEA registration befor
 e the rule is final.\n\nOfficial notice: https://dsd.maryland.gov/MDRIssue
 s/5322/Assembled.aspx\nRegulatory Radar: https://www.sainthealthgroup.com/
 radar/2026-11-12#md-26-190-p-proposed
URL:https://www.sainthealthgroup.com/radar/2026-11-12#md-26-190-p-proposed
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
